Vireo Growth Inc. (VREOF)
OTCMKTS · Delayed Price · Currency is USD
0.6800
+0.0020 (0.29%)
Oct 16, 2025, 4:00 PM EDT
Vireo Growth Market Cap
Vireo Growth has a market cap or net worth of $649.20 million as of October 16, 2025. Its market cap has increased by 470.66% in one year.
Market Cap
649.20M
Enterprise Value
713.27M
Revenue
122.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.68
Market Cap Chart
Since March 20, 2019, Vireo Growth's market cap has increased from 296.29M to 649.20M, an increase of 119.11%. That is a compound annual growth rate of 12.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 677.04M | 227.66% |
| Dec 31, 2024 | 206.63M | 498.26% |
| Dec 29, 2023 | 34.54M | 69.69% |
| Dec 30, 2022 | 20.35M | -90.69% |
| Dec 31, 2021 | 218.67M | 51.51% |
| Dec 31, 2020 | 144.33M | 59.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 698.88M |
| Elite Pharmaceuticals | 663.06M |
| Veradigm | 514.01M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 367.43M |
| CytoDyn | 350.21M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 275.85M |